Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
Epigenetic Drugs: Team Players in Combo Therapies
Scientists May Be Better Able to Destroy Tumors and Possibly Reverse CNS Decline
Toward a Universal Flu Vaccine
New Candidate Fights Back against the Flu’s Efforts to Undermine the Human Immune System
Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
For full access to this article login to GEN Select now.
Encouraging Suppliers to Communicate
Earnest Discourse Early and Often Provides Better Outcomes and Increased Customer Satisfaction
- Last year, when ATM and cash register manufacturer NCR moved its European manufacturing plants to the U.S., one of its early efforts was to gather 260 of its suppliers together at Georgia Tech to leverage their knowledge. “It was fantastic to see the level of innovation,” recalled Peter Dorsman, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.